Low dosE GlibENclamide in Diabetes Part A

NCT02830048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Glibenclamide

Sponsor

University of Oxford

Collaborators

[object Object]